PROMISE - Program Refinements to Optimize Model Impact and Scalability based on Evidence

PROMISE - 基于证据优化模型影响和可扩展性的程序改进

基本信息

项目摘要

Abstract In New York, the achievement of 90-90-90 goals is jeopardized not by limited access to affordable care and treatment, but by persistent disparities in HIV viral suppression (VS). Complex behavioral and structural barriers to achieving and maintaining VS require coordinated, combination approaches to meet medical and social service needs. In 2009, at 28 Ryan White Part A (RWPA)-funded agencies, the New York City (NYC) Department of Health and Mental Hygiene (DOHMH) launched a multi-component HIV Care Coordination Program (CCP) directed toward the most vulnerable, high-need persons living with HIV (PLWH) in NYC. A systematic CCP effectiveness study began in 2013 (R01 MH101028; PIs: Irvine, Nash). Findings to date suggest that the CCP is superior to usual care for high-need subgroups of PLWH, but there remains substantial room for improvement in short- and long-term VS. In an immediate evidence-to- practice feedback loop, the DOHMH is implementing a refined CCP model in 2018. Greater focusing, tailoring and cues for delivery of key components are expected to increase CCP engagement, reach, fidelity, scalability, effectiveness and impact. The aims of the proposed study are to: 1) Estimate the effectiveness of the revised (vs. original) CCP on timely VS (≤4 months), using experimental methods (Aim 1); 2) Estimate the effectiveness of the revised CCP (vs. `usual care') on longer-term VS, including VS at 12 months and durable viral suppression (DVS) at 24-36 months, using rigorous observational comparison group methods (Aim 2); and 3) Identify attributes and drivers of provider and client engagement in the intervention and provider and client preferences for future revised-CCP delivery and receipt (Aim 3). Prior studies have not demonstrated any intervention to be effective at improving short- and long-term VS among the many PLWH with major barriers to HIV care continuum engagement. The proposed study, to be conducted on a large scale in real-world HIV service settings, will document the rollout and effects of evidence-informed implementation course corrections to an intervention model focused on these most vulnerable PLWH. In this way, the work will advance a second generation of interventions capable of strengthening the care continuum among PLWH who have been unable to achieve desired ART outcomes in existing interventions, due to major structural or psychosocial barriers.
摘要

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
HIV Care Coordination promotes care re-engagement and viral suppression among people who have been out of HIV medical care: an observational effectiveness study using a surveillance-based contemporaneous comparison group.
艾滋病毒护理协调促进了脱离艾滋病毒医疗护理的人的护理重新参与和病毒抑制:使用基于监视的同时比较组的观察有效性研究。
  • DOI:
    10.1186/s12981-021-00398-0
  • 发表时间:
    2021-10-12
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Irvine MK;Robertson MM;Nash D;Kulkarni SG;Braunstein SL;Levin B
  • 通讯作者:
    Levin B
Provider preferences for delivery of HIV care coordination services: results from a discrete choice experiment.
  • DOI:
    10.1002/jia2.25887
  • 发表时间:
    2022-03
  • 期刊:
  • 影响因子:
    6
  • 作者:
    Zimba R;Fong C;Conte M;Baim-Lance A;Robertson M;Carmona J;Gambone G;Nash D;Irvine M
  • 通讯作者:
    Irvine M
Mortality among clients in the New York city HIV Care Coordination Program (CCP): incidence and associated clinical factors.
  • DOI:
    10.1016/j.annepidem.2021.10.001
  • 发表时间:
    2021-12
  • 期刊:
  • 影响因子:
    5.6
  • 作者:
    Robertson MM;Irvine MK;Penrose K;Harriman G;Braunstein SL;Nash D
  • 通讯作者:
    Nash D
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mary Kathryn Irvine其他文献

Mary Kathryn Irvine的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mary Kathryn Irvine', 18)}}的其他基金

Assessing Perceptions and Preferences around Long-acting Injectables (APPLI) in the Ryan White HIV/AIDS Program
评估 Ryan White HIV/AIDS 项目中对长效注射剂 (APPLI) 的看法和偏好
  • 批准号:
    10394420
  • 财政年份:
    2021
  • 资助金额:
    $ 50.56万
  • 项目类别:
Strengthening the Safety Net: Testing a Novel Data-to-Suppression (D2S) Intervention Strategy in the Ryan White HIV/AIDS Program
加强安全网:在 Ryan White HIV/AIDS 项目中测试新型数据抑制 (D2S) 干预策略
  • 批准号:
    10438934
  • 财政年份:
    2021
  • 资助金额:
    $ 50.56万
  • 项目类别:
Assessing Perceptions and Preferences around Long-acting Injectables (APPLI) in the Ryan White HIV/AIDS Program
评估 Ryan White HIV/AIDS 项目中对长效注射剂 (APPLI) 的看法和偏好
  • 批准号:
    10256883
  • 财政年份:
    2021
  • 资助金额:
    $ 50.56万
  • 项目类别:
Strengthening the Safety Net: Testing a Novel Data-to-Suppression (D2S) Intervention Strategy in the Ryan White HIV/AIDS Program
加强安全网:在 Ryan White HIV/AIDS 项目中测试新型数据抑制 (D2S) 干预策略
  • 批准号:
    10615110
  • 财政年份:
    2021
  • 资助金额:
    $ 50.56万
  • 项目类别:
Assessing Perceptions and Preferences around Long-acting Injectables (APPLI) in the Ryan White HIV/AIDS Program
评估 Ryan White HIV/AIDS 项目中对长效注射剂 (APPLI) 的看法和偏好
  • 批准号:
    10598553
  • 财政年份:
    2021
  • 资助金额:
    $ 50.56万
  • 项目类别:
Strengthening the Safety Net: Testing a Novel Data-to-Suppression (D2S) Intervention Strategy in the Ryan White HIV/AIDS Program
加强安全网:在 Ryan White HIV/AIDS 项目中测试新型数据抑制 (D2S) 干预策略
  • 批准号:
    10326932
  • 财政年份:
    2021
  • 资助金额:
    $ 50.56万
  • 项目类别:
PROMISE - Program Refinements to Optimize Model Impact and Scalability based on Evidence
PROMISE - 基于证据优化模型影响和可扩展性的程序改进
  • 批准号:
    10083232
  • 财政年份:
    2018
  • 资助金额:
    $ 50.56万
  • 项目类别:
HIV care coordination: comparative effectiveness, outcome determinants and costs
艾滋病毒护理协调:比较有效性、结果决定因素和成本
  • 批准号:
    9340280
  • 财政年份:
    2016
  • 资助金额:
    $ 50.56万
  • 项目类别:
HIV care coordination: comparative effectiveness, outcome determinants and costs
艾滋病毒护理协调:比较有效性、结果决定因素和成本
  • 批准号:
    8659691
  • 财政年份:
    2013
  • 资助金额:
    $ 50.56万
  • 项目类别:
HIV care coordination: comparative effectiveness, outcome determinants and costs
艾滋病毒护理协调:比较有效性、结果决定因素和成本
  • 批准号:
    8743278
  • 财政年份:
    2013
  • 资助金额:
    $ 50.56万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 50.56万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 50.56万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 50.56万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 50.56万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 50.56万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 50.56万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 50.56万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 50.56万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 50.56万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 50.56万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了